Interstitial pneumonitis as a late complication of high dose therapy with cyclophosphamide/thiotepa and peripheral blood progenitor cell rescue for carcinoma of the breast-Reference-Cited by-同舟云学术

Interstitial pneumonitis as a late complication of high dose therapy with cyclophosphamide/thiotepa and peripheral blood progenitor cell rescue for carcinoma of the breast

Published:1996-01 Issue:3 Volume:8 Page:198-200
ISSN:0936-6555
Container-title:Clinical Oncology
language:en
Short-container-title:Clinical Oncology

Author:

Mahendra P.,Hood I.M.,Lee M.A.,Mewar D.,Bass G.,Flower C.D.R.,Wilson C.B.,Marcus R.E.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference6 articles.

1. High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant chemotherapy for high-risk primary breast cancer;Peters;J Clin Oncol,1993

2. The EBMT Solid Tumours Working Party analysis on breast cancer: 1994 update;Rosti;Bone Marrow Transplant,1995

3. The diagnosis and management of early complications;Kanfer,1992

4. Dose intensive chemotherapy can be safely administered in an outpatient setting: Results of a multicentre trial;West;Clin Oncol,1993

5. Autologous bone marrow transplant (ABMT) for non-Hodgkin's (NHL) and Hodgkin's lymphoma using a thiotepa-based preparative regimen;Damon;Blood,1994

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antineoplastic therapy-induced pulmonary toxicity;Expert Review of Anticancer Therapy;2013-08

2. Severe interstitial pneumonitis following high-dose cyclophosphamide, thiotepa and docetaxel: two case reports and a review of the literature;Bone Marrow Transplantation;2001-03

3. Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study;Bone Marrow Transplantation;2000-11

4. The authors reply as follows;Clinical Oncology;1998-01

5. Interstitial pneumonitis as a late complication of high dose therapy with cyclophosphamide/thiotepa and peripheral blood progenitor cell rescue for carcinoma of the breast;Clinical Oncology;1998-01